Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Michael Palladino"'
Autor:
Olivia S. Costa, Stanley Thompson, Veronica Ashton, Michael Palladino, Thomas J. Bunz, Craig I. Coleman
Publikováno v:
Thrombosis Journal, Vol 18, Iss 1, Pp 1-9 (2020)
Abstract Background African Americans are under-represented in trials evaluating oral anticoagulants for the treatment of acute venous thromboembolism (VTE). The aim of this study was to evaluate the effectiveness and safety of rivaroxaban versus war
Externí odkaz:
https://doaj.org/article/e51d1e5c7f5d4f8bbe36ce907d2c77f3
The novel proteasome inhibitor NPI-0052 has been shown to sensitize tumor cells to apoptosis by various chemotherapeutic drugs and tumor necrosis factor–related apoptosis-inducing ligand (TRAIL), although the mechanisms involved are not clear. We h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a42c8612faa5625661bb081277d2a073
https://doi.org/10.1158/0008-5472.c.6499683.v1
https://doi.org/10.1158/0008-5472.c.6499683.v1
Supplementary Figure Legend from Pivotal Roles of Snail Inhibition and RKIP Induction by the Proteasome Inhibitor NPI-0052 in Tumor Cell Chemoimmunosensitization
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50bba1a334c637d10ed98451b5cc3ce9
https://doi.org/10.1158/0008-5472.22380810
https://doi.org/10.1158/0008-5472.22380810
Supplementary Figure 1 from Pivotal Roles of Snail Inhibition and RKIP Induction by the Proteasome Inhibitor NPI-0052 in Tumor Cell Chemoimmunosensitization
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2005023bf1f9e14d7609ec5c94023bb6
https://doi.org/10.1158/0008-5472.22380813.v1
https://doi.org/10.1158/0008-5472.22380813.v1
Autor:
Matteo Bergamino, Andrea Vongher, Firas Mourad, James Dunning, Giacomo Rossettini, Michael Palladino, Cesar Fernández-de-las-Peñas, Marco Testa, Filippo Maselli
Publikováno v:
Journal of manipulative and physiological therapeutics. 45(2)
The purpose of this study was to assess whether beliefs about the origin of the popping sound and the effects of thrust manipulation (TM) were in agreement with current scientific evidence and whether a practitioner's explanation could influence pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66edbc6e2b080b4dbc01997e1d235a1f
https://pubmed.ncbi.nlm.nih.gov/35753885
https://pubmed.ncbi.nlm.nih.gov/35753885
Autor:
Giacomo Rossettini, Valerio Barbari, Marco Testa, Filippo Maselli, Lorenzo Storari, Michael Palladino
Red Flags (RFs) are signs and symptoms related to the screening of serious underlying pathologies mimicking a musculoskeletal pain. The current literature wonders about the usefulness of RFs, due to high false-positive rates and low diagnostic accura
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9198ff3e5db215065724527012742455
http://hdl.handle.net/11567/1023752
http://hdl.handle.net/11567/1023752
Publikováno v:
Journal of the American College of Cardiology. 75:338
Introduction Black patients are under-represented in randomized trials evaluating oral anticoagulants in non-valvular atrial fibrillation (NVAF). We sought to evaluate the effectiveness and safety of rivaroxaban versus warfarin in African Americans w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3cd609ac9dbc43e86dac00e5fc9c6a7
https://doi.org/10.1016/s0735-1097(20)30965-7
https://doi.org/10.1016/s0735-1097(20)30965-7
Publikováno v:
Expert Opinion on Investigational Drugs. 22:1465-1472
For over 60 years vitamin K antagonists have been the mainstay of oral therapy for treatment and prevention of venous and arterial thromboembolic disease. The emergence of two new classes of orally administered anticoagulants, direct thrombin and fac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::078668dbebbcc7b2fbb4ceeb6351e4ff
https://doi.org/10.1517/13543784.2013.825605
https://doi.org/10.1517/13543784.2013.825605
Publikováno v:
Journal of Thrombosis and Thrombolysis. 31:310-320
The new oral anticoagulants may prove to be one of the most significant innovations in clinical practice in the past 60 years. Apixaban and rivaroxaban are specific inhibitors of Factor Xa while dabigatran inhibits Factor IIa. The predictable pharmac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85032c514e91d6acb51a6366e182e789
https://doi.org/10.1007/s11239-011-0559-8
https://doi.org/10.1007/s11239-011-0559-8
Autor:
Geno J. Merli, Michael Palladino, Glenn Oettinger, Robert Pugliese, Taki Galanis, Laura Falconieri, Lynda Thomson
Publikováno v:
Hospital practice (1995). 42(4)
Patients presenting to the emergency department (ED) with an acute uncomplicated deep vein thrombosis (DVT) may be eligible for outpatient treatment. This study aims to establish a transition of care program in the ED for patients with DVT presenting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05601d5cb4082faf9e4d564187b1dd36
https://pubmed.ncbi.nlm.nih.gov/25502127
https://pubmed.ncbi.nlm.nih.gov/25502127